Class information for:
Level 1: BUSULFAN//TREOSULFAN//INTRAVENOUS BUSULFAN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
13307 782 31.4 78%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
233 19645 BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BUSULFAN Author keyword 148 48% 29% 227
2 TREOSULFAN Author keyword 27 49% 5% 39
3 INTRAVENOUS BUSULFAN Author keyword 14 65% 2% 13
4 IV BUSULFAN Author keyword 11 100% 1% 6
5 BU Author keyword 10 48% 2% 15
6 BUSULPHAN Author keyword 7 32% 2% 18
7 HEPSULFAM Author keyword 6 80% 1% 4
8 CONDITIONING REGIMEN Author keyword 4 18% 3% 21
9 BUSULFAN PHARMACOKINETICS Author keyword 4 75% 0% 3
10 ORAL BUSULFAN Author keyword 4 75% 0% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 BUSULFAN 148 48% 29% 227 Search BUSULFAN Search BUSULFAN
2 TREOSULFAN 27 49% 5% 39 Search TREOSULFAN Search TREOSULFAN
3 INTRAVENOUS BUSULFAN 14 65% 2% 13 Search INTRAVENOUS+BUSULFAN Search INTRAVENOUS+BUSULFAN
4 IV BUSULFAN 11 100% 1% 6 Search IV+BUSULFAN Search IV+BUSULFAN
5 BU 10 48% 2% 15 Search BU Search BU
6 BUSULPHAN 7 32% 2% 18 Search BUSULPHAN Search BUSULPHAN
7 HEPSULFAM 6 80% 1% 4 Search HEPSULFAM Search HEPSULFAM
8 CONDITIONING REGIMEN 4 18% 3% 21 Search CONDITIONING+REGIMEN Search CONDITIONING+REGIMEN
9 BUSULFAN PHARMACOKINETICS 4 75% 0% 3 Search BUSULFAN+PHARMACOKINETICS Search BUSULFAN+PHARMACOKINETICS
10 ORAL BUSULFAN 4 75% 0% 3 Search ORAL+BUSULFAN Search ORAL+BUSULFAN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HIGH DOSE BUSULFAN 99 58% 15% 114
2 ORAL BUSULFAN 68 80% 5% 43
3 INTRAVENOUS BUSULFAN 43 55% 7% 54
4 DAILY IV BUSULFAN 34 79% 3% 22
5 INTRAVENOUS TREOSULFAN 32 85% 2% 17
6 DAILY INTRAVENOUS BUSULFAN 32 49% 6% 47
7 CONDITIONING THERAPY 29 77% 3% 20
8 PREPARATIVE REGIMEN 28 31% 10% 77
9 BUCY2 23 86% 2% 12
10 IV BUSULFAN 21 78% 2% 14

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Busulfan in Hematopoietic Stem Cell Transplantation 2009 50 96 72%
Busulfan in hematopoietic stem cell transplant setting 2009 25 88 78%
Plasma concentration monitoring of busulfan - Does it improve clinical outcome? 2000 79 40 90%
Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics 2014 2 88 80%
Therapeutic drug monitoring of busulfan in transplantation 2008 29 149 85%
Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike 2012 14 74 43%
Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfan 2013 3 108 78%
Quantification of busulfan in saliva and plasma in haematopoietic stem cell transplantation in children 2006 18 40 73%
Review of therapeutic drug monitoring of anticancer drugs part 1-Cytotoxics 2014 8 78 17%
The role of busulfan in bone marrow transplantation 1999 35 92 71%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ALBERTA BLOOD MARROW TRANSPLANT PROGRAM 3 50% 0.6% 5
2 PHARMACEUT MED CHEM CLIN PHARM 3 57% 0.5% 4
3 UNIV HEMATOL BMT 2 67% 0.3% 2
4 CANSEARCH 1 38% 0.4% 3
5 MED CLIN HEMATOL ONCOL 3 1 50% 0.3% 2
6 PAEDIAT IMMUNOHAEMATOL BONE MARROW TRANSPL 1 50% 0.3% 2
7 PEDIATSTEM CELL TRANSPLANT PROGRAM 1 50% 0.3% 2
8 CHARLES BRUNEAU CANC 1 21% 0.6% 5
9 KFC 1 11% 1.0% 8
10 PHYS PHARM PHARMACOKINET 1 12% 0.9% 7

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000234399 INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN//MEDITERRANEAN HEMATOL//TR IANTO MIDOLLO OSSEO MURAGLIA
2 0.0000223423 DEFIBROTIDE//VENO OCCLUSIVE DISEASE//HEPATIC VENO OCCLUSIVE DISEASE
3 0.0000179246 REDUCED INTENSITY CONDITIONING//DONOR LYMPHOCYTE INFUSION//REDUCED INTENSITY
4 0.0000166667 TOTAL BODY IRRADIATION//TOTAL MARROW IRRADIATION//OCULAR GRAFT VERSUS HOST DISEASE
5 0.0000087946 N N N TRIETHYLENEPHOSPHORAMIDE//THIOTEPA MERCAPTURATE//TEPA
6 0.0000073005 TRANSPLANT RATES//EBMT ACT SURVEY OFF//OPERAT COMPUTAT FINANCE
7 0.0000072920 GENITAL GVHD//CARDIAC LATE EFFECTS//HCT HEMATOPOIETIC CELL TRANSPLANTATION
8 0.0000072136 CLOFARABINE//CANC THER EUT IMMUNOL//NELARABINE
9 0.0000069992 ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML
10 0.0000068271 ETOPOSIDE PHOSPHATE//ETOPOSIDE//ORAL ETOPOSIDE